← Open Payments lookup

RANDAL SCHOLMA: Open Payments

NPI 1558574566 · LOWELL, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$29,308 in 127 payments from 13 companies in 2025. Trend: 2023 $13,076 · 2024 $15,672 · 2025 $29,308

Honoraria: $22,039Food & beverage: $3,143Speaker / faculty: $2,250Travel & lodging: $1,793Education: $84
CompanyPaymentsAmount
Axsome Therapeutics, Inc.32$24,925
ABBVIE INC.19$2,589
Alkermes, Inc.18$458
Teva Pharmaceuticals USA, Inc.8$252
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$212
Neurocrine BioSciences, Inc.9$206
Vanda Pharmaceuticals Inc.6$157
Janssen Pharmaceuticals, Inc5$111
E.R. Squibb & Sons, L.L.C.5$106
Corium, LLC4$103

Products named: Auvelity, VRAYLAR, ARISTADA, CAPLYTA, INGREZZA, AUSTEDO XR, REXULTI, HETLIOZ.

Industry payments across AR — which companies pay providers there.